在OGTT之前查禁食葡萄糖:靠近患者的葡萄糖计或基于实验室的测量?
Giuseppe Lippi1,2, Anna Ferrari2, Sara Visconti2
1Section of Clinical Biochemistry, University of Verona, Verona, Italy.
Diagnosis (Berlin, Germany)
|December 8, 2024
概括
临近患者的葡萄糖计查禁食葡萄糖提供更快的结果,但显示出更高的不精确性和成本. 实验室分析为口服葡萄糖耐受性测试提供了更高的准确性.
科学领域:
- 临床化学 临床化学
- 照顾点检测检测 照顾点检测
- 糖尿病查 糖尿病查
背景情况:
- 在口服葡萄糖耐受性测试 (OGTT) 之前,禁食葡萄糖测量对于高血糖风险评估至关重要.
- 临近患者测试提供了传统实验室分析的替代方案,以检测毛细血管禁食葡萄糖.
研究的目的:
- 为了比较近病人的葡萄糖计测量毛细血管快食葡萄糖的优点和局限性,与血葡萄糖的实验室测量.
主要方法:
- 一项涉及241名受试者 (主要是孕妇) 接受OGTT的研究.
- 禁食葡萄糖被测量使用近患者的葡萄糖计 (毛细血管血液) 和实验室仪器 (血,六酶测定).
主要成果:
- 血糖计测试的回报时间更快 (8秒比32分钟),但不精确度更高 (3.4%比0.8%) 和负偏差 (-3.3%).
- 禁食葡萄糖≥7.0mmol/L的诊断准确度很高 (99.2%),敏感度为50.0%,特异性为100.0%.
- 葡萄糖计策略的附加成本略高 (每名患者0.17欧元).
结论:
- 临近患者的葡萄糖计查使得瘤中心的患者管理更快.
- 然而,与实验室血葡萄糖检测相比,这种方法与不精确性,不准确性,成本和不必要的指尖刺伤增加有关.
更多相关视频
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Published on: March 15, 2018
14.1K
06:59Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
Published on: November 13, 2016
10.9K
相关概念视频
Hypoglycemia and Glucagon
152
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
152
Oral Hypoglycemic Agents: Glinides
139
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
139
Diabetes: Symptoms, Diagnosis, and Complications
504
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
504
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Glucose Homeostasis: Regulation of Blood Glucose
1.4K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
1.4K
